These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 19822978)

  • 1. Association of antiplatelet therapy with lower risk of death and recurrent cerebrovascular events after ischemic stroke--results from the China Ischemic Stroke Registry Study.
    Ding D; Lu CZ; Fu JH; Hong Z;
    Circ J; 2009 Dec; 73(12):2342-7. PubMed ID: 19822978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors of vascular events after ischemic stroke: the China ischemic stroke registry study.
    Ding D; Lu CZ; Fu JH; Hong Z
    Neuroepidemiology; 2010; 34(2):110-6. PubMed ID: 20051694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors of one-year disability and death in Chinese hospitalized women after ischemic stroke.
    Kong FY; Tao WD; Hao ZL; Liu M
    Cerebrovasc Dis; 2010 Feb; 29(3):255-62. PubMed ID: 20029199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clopidogrel Resistance Increases Rate of Recurrent Stroke and Other Vascular Events in Chinese Population.
    Yi X; Lin J; Zhou Q; Wu L; Cheng W; Wang C
    J Stroke Cerebrovasc Dis; 2016 May; 25(5):1222-1228. PubMed ID: 26935114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discontinuation of antiplatelet treatment and risk of recurrent stroke and all-cause death: a cohort study.
    Ostergaard K; Pottegård A; Hallas J; Bak S; dePont Christensen R; Gaist D
    Neuroepidemiology; 2014; 43(1):57-64. PubMed ID: 25323533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors for poor outcome and mortality at 3 months after the ischemic stroke in patients with atrial fibrillation.
    Li S; Zhao X; Wang C; Liu L; Liu G; Wang Y; Wang C; Jing J; Wang YJ
    J Stroke Cerebrovasc Dis; 2013 Nov; 22(8):e419-25. PubMed ID: 23721617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of Oral Antiplatelet Agents and Tirofiban on Functional Outcomes of Patients with Non-Disabling Minor Acute Ischemic Stroke.
    Wang H; Li X; Liu C; Huang S; Liang C; Zhang M
    J Stroke Cerebrovasc Dis; 2020 Aug; 29(8):104829. PubMed ID: 32689578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of Antiplatelet Therapy (Aspirin + Dipyridamole Versus Clopidogrel) on Mortality Outcome in Ischemic Stroke.
    Barlas RS; Loke YK; Mamas MA; Bettencourt-Silva JH; Ford I; Clark AB; Bowles KM; Metcalf AK; Potter JF; Myint PK
    Am J Cardiol; 2018 Sep; 122(6):1085-1090. PubMed ID: 30072125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and Efficacy of Prasugrel in Elderly/Low Body Weight Japanese Patients with Ischemic Stroke: Randomized PRASTRO-II.
    Kitagawa K; Toyoda K; Kitazono T; Nishikawa M; Nanto S; Ikeda Y; Abe K; Ogawa A
    Cerebrovasc Dis; 2020; 49(2):152-159. PubMed ID: 32208397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Initial Stroke Severity in Patients With Atrial Fibrillation According to Antithrombotic Therapy Before Ischemic Stroke.
    Jung YH; Kim YD; Kim J; Han SW; Oh MS; Lee JS; Lee KY
    Stroke; 2020 Sep; 51(9):2733-2741. PubMed ID: 32811392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment with Clopidogrel Prior to Acute Non-Cardioembolic Ischemic Stroke Attenuates Stroke Severity.
    Tziomalos K; Giampatzis V; Bouziana SD; Spanou M; Kostaki S; Papadopoulou M; Angelopoulou SM; Tsopozidi M; Savopoulos C; Hatzitolios AI
    Cerebrovasc Dis; 2016; 41(5-6):226-32. PubMed ID: 26795462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of aspirin on risk and severity of early recurrent stroke after transient ischaemic attack and ischaemic stroke: time-course analysis of randomised trials.
    Rothwell PM; Algra A; Chen Z; Diener HC; Norrving B; Mehta Z
    Lancet; 2016 Jul; 388(10042):365-375. PubMed ID: 27209146
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Triple versus guideline antiplatelet therapy to prevent recurrence after acute ischaemic stroke or transient ischaemic attack: the TARDIS RCT.
    Bath PM; Woodhouse LJ; Appleton JP; Beridze M; Christensen H; Dineen RA; Flaherty K; Duley L; England TJ; Havard D; Heptinstall S; James M; Kasonde C; Krishnan K; Markus HS; Montgomery AA; Pocock S; Randall M; Ranta A; Robinson TG; Scutt P; Venables GS; Sprigg N
    Health Technol Assess; 2018 Aug; 22(48):1-76. PubMed ID: 30179153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiplatelet Agents for the Secondary Prevention of Ischemic Stroke or Transient Ischemic Attack: A Network Meta-Analysis.
    Wang W; Zhang L; Liu W; Zhu Q; Lan Q; Zhao J
    J Stroke Cerebrovasc Dis; 2016 May; 25(5):1081-1089. PubMed ID: 26856461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Baseline characteristics of the 3096 patients recruited into the 'Triple Antiplatelets for Reducing Dependency after Ischemic Stroke' trial.
    Bath PM; Appleton JP; Beridze M; Christensen H; Dineen RA; Duley L; England TJ; Heptinstall S; James M; Krishnan K; Markus HS; Pocock S; Ranta A; Robinson TG; Flaherty K; Scutt P; Venables GS; Woodhouse LJ; Sprigg N
    Int J Stroke; 2017 Jul; 12(5):524-538. PubMed ID: 27811309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelet function/reactivity testing and prediction of risk of recurrent vascular events and outcomes after TIA or ischaemic stroke: systematic review and meta-analysis.
    Lim ST; Thijs V; Murphy SJX; Fernandez-Cadenas I; Montaner J; Offiah C; Marquardt L; Kelly PJ; Bath PM; Lim SY; Ford GA; Norrving B; Cox D; Prodan CI; Barber PA; Werring DJ; Perry R; Zgaga L; Dawson J; McCabe DJH
    J Neurol; 2020 Oct; 267(10):3021-3037. PubMed ID: 32518978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risks and Benefits Associated With Prestroke Antiplatelet Therapy Among Patients With Acute Ischemic Stroke Treated With Intravenous Tissue Plasminogen Activator.
    Xian Y; Federspiel JJ; Grau-Sepulveda M; Hernandez AF; Schwamm LH; Bhatt DL; Smith EE; Reeves MJ; Thomas L; Webb L; Bettger JP; Laskowitz DT; Fonarow GC; Peterson ED
    JAMA Neurol; 2016 Jan; 73(1):50-9. PubMed ID: 26551916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Statin and Aspirin Pretreatment Are Associated with Lower Neurological Deterioration and Platelet Activity in Patients with Acute Ischemic Stroke.
    Yi X; Han Z; Wang C; Zhou Q; Lin J
    J Stroke Cerebrovasc Dis; 2017 Feb; 26(2):352-359. PubMed ID: 27793535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness and safety of antiplatelet in stroke patients with end-stage renal disease undergoing dialysis.
    Chen CY; Lee KT; Lee CT; Lai WT; Huang YB
    Int J Stroke; 2014 Jul; 9(5):580-90. PubMed ID: 24597578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Warfarin and Antiplatelet Therapy Versus Warfarin Alone for Treating Patients With Atrial Fibrillation Undergoing Transcatheter Aortic Valve Replacement.
    Abdul-Jawad Altisent O; Durand E; Muñoz-García AJ; Nombela-Franco L; Cheema A; Kefer J; Gutierrez E; Benítez LM; Amat-Santos IJ; Serra V; Eltchaninoff H; Alnasser SM; Elízaga J; Dager A; García Del Blanco B; Ortas-Nadal Mdel R; Marsal JR; Campelo-Parada F; Regueiro A; Del Trigo M; Dumont E; Puri R; Rodés-Cabau J
    JACC Cardiovasc Interv; 2016 Aug; 9(16):1706-17. PubMed ID: 27539691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.